REGEN BIOPHARMA, INC. Proceeds from (Repayments of) Notes Payable
REGEN BIOPHARMA, INC. (RGBP) reported Proceeds from (Repayments of) Notes Payable of $0 for the 6-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfNotesPayable · last filed 2026-05-14
- REGEN BIOPHARMA, INC. proceeds from (repayments of) notes payable for the quarter ending 2026-03-31 was $58.84K.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) notes payable for the quarter ending 2025-12-31 was -$58.84K.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) notes payable for the quarter ending 2024-09-30 was $118.00K.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) notes payable for the quarter ending 2024-06-30 was $21.00K.
- REGEN BIOPHARMA, INC. proceeds from (repayments of) notes payable for fiscal 2024 was $77.49K.
| Period end | Proceeds from (Repayments of) Notes Payable 3 month | Proceeds from (Repayments of) Notes Payable 6 month | Proceeds from (Repayments of) Notes Payable 9 month | Proceeds from (Repayments of) Notes Payable 12 month | Proceeds from (Repayments of) Notes Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $58.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | $0.00 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$58.84K 10-Q · filed 2026-02-13 | ||||
| 2025-03-31 | $168.66K 10-Q · filed 2025-05-28 | ||||
| 2024-09-30 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-30 | $138.99K derived: sum of 2 quarters · filed 2025-12-30 | $123.99K derived: sum of 3 quarters · filed 2025-12-30 | $77.49K 10-K · filed 2025-12-30 | $19.13K 8-K · filed 2024-11-29 |
| 2024-06-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-11 | $6.00K derived: sum of 2 quarters · filed 2025-08-11 | -$40.50K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | -$61.50K 10-Q · filed 2025-05-28 | |||
| 2023-12-31 | -$46.50K 10-Q · filed 2024-01-19 | ||||
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-13 | ||||
| 2022-12-31 | $0.00 10-Q · filed 2024-01-19 |